T. Rowe Price Associates’s Lifestance Health LFST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $406K | Buy |
78,456
+5,677
| +8% | +$29.4K | ﹤0.01% | 2399 |
|
2025
Q1 | $485K | Buy |
72,779
+5,924
| +9% | +$39.5K | ﹤0.01% | 2254 |
|
2024
Q4 | $493K | Buy |
66,855
+9,009
| +16% | +$66.4K | ﹤0.01% | 2282 |
|
2024
Q3 | $405K | Buy |
57,846
+8,015
| +16% | +$56.1K | ﹤0.01% | 2341 |
|
2024
Q2 | $245K | Buy |
49,831
+7,465
| +18% | +$36.7K | ﹤0.01% | 2508 |
|
2024
Q1 | $262K | Buy |
42,366
+4,681
| +12% | +$28.9K | ﹤0.01% | 2497 |
|
2023
Q4 | $296K | Buy |
37,685
+1,933
| +5% | +$15.2K | ﹤0.01% | 2379 |
|
2023
Q3 | $246K | Buy |
35,752
+2,455
| +7% | +$16.9K | ﹤0.01% | 2418 |
|
2023
Q2 | $305K | Buy |
33,297
+19,674
| +144% | +$180K | ﹤0.01% | 2354 |
|
2023
Q1 | $102K | Buy |
13,623
+1,294
| +10% | +$9.69K | ﹤0.01% | 2684 |
|
2022
Q4 | $61K | Buy |
12,329
+1,127
| +10% | +$5.58K | ﹤0.01% | 2788 |
|
2022
Q3 | $75K | Buy |
+11,202
| New | +$75K | ﹤0.01% | 2779 |
|
2021
Q3 | – | Sell |
-14,094
| Closed | -$393K | – | 2962 |
|
2021
Q2 | $393K | Buy |
+14,094
| New | +$393K | ﹤0.01% | 2480 |
|